Атлас лучевой диагностики опухолей опорно-двигательного аппарата - Веснин А.Г.
Скачать (прямая ссылка):
1,2,3,4-tetrahydro-
isochinolin-l,3-dion
wx$X’ -
H3C CH3
7-Methoxy-214J4-trimethyt-
^^i-tettahydroisoctvnoUn,-
1,3-dion
; NaOH 2. H?SOt,
H3C РЎРќР·
L.J+-Dimethyl-7-methoxy-1,2,3,4-tatiahydroisochroman -1,3-dion
НэН“СНг~СНг~<^~^-'50г— NH*
i-(2-Aminoethyt)-berzol5Ulfon'
amid
РќР·РЎ РЎРќР·
РљРћРЎ1РЎРќСЌР > o=c-n^^2)
Kalium- Cyclohexyliso-ferf-butylat eyanat
РќР·РЎРћ^^Р— ^Ha-CH2H0HSO2-NH-C-NH^)
"0 РќР·РЎ' 'РЎРќР·
Gliquidon
DOTH, 281 (1975); 16, 47 (1980).
DAS 2000339 (Thomae; Anm. 5.1.1970).
DOS 2011126 (Thomae; Anm. 10.3.1970).
USP 3708486 (Boehringer Ing.; ert. 2.1.1973; D-Prior. 5.1.1970 u. 17.4.1969).
D: GlurenormВ® (Thomae) GB: GlurenormВ® (Winthrop)
GliSOXepid 25046-79-1 Antidiabeticum
l-(hexahydro-l//-azepin-l-yl)-3-[[p-[2-(5-methyl-3-isoxazolecarboxamido)ethyl]phenyl]sulfonyI]urea
1. sect-,
H3C^В°^N Рі. h,n-ch,-ch,-^Q>-soi-nh; ^ ^-"РіР“0^
*—2. 4-[2'Aminoethyi)-benzolsuifonamid '—*•(. // 'S.
C00H \-NH-CH2-CH24^_VS02--NH2
5- Methyl isoxazol- ^
3-carbonsaure
446 G Glisoxepid - Glucametacin - Glutethimid
_асоосн3/к7со^
Chlorarneisen-
sauremsthyl-
ester
РќР·РЎР§>
//
0
'C-NH-CHi-CHt-f VSO2-NH-COOCH3
РќР—РЎ^Р“
1-Ammohexa-rrethyleflimm [i !-Amir>ohexa-hydroaseoin)
C-NH-CH2-CH2-lf V-SO2-NH-C-NH-N
4 0
Glisoxepid
DOT 10,257 (1974); 16,15 (1980).
DBP 1670952 (Bayer; Anm. 25.11.1967).
USP 3 668 215 (Bayer; ert. 6.6.1972; D-Prior. 25.11.1967). H. Pliimpe et al., Aizneim. Forsch. 24,363 (1974).
D: Р РіРѕ-DiabanВ® (Bayer/Schering)
Glucametacin
52443-21-7
Antiphlogisticum
2-[2-[l-(p-chIorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetamido]2-deoxy-D-glucose
С‹
\
N.
hooc—chz
'РћРЎРќР·
Indometacm
(S. S. 488)
S0Cl2
Thionyl-
chlorid
N.
H3C^ CiOC-CHz
OCH3
1 - (4 - Chtor benzoy () - 2-methyl-5-methoxyindolyl-3-es5igsaurechlond
CH2OH <ВЈ> MO OH
a-D-Olucosamin-
Hydrochlorid
CH20H )-В°v
0
N.
РќР·РЎРќРЎ
РѕРЅ
NH-C0-CH2
0CH3
DOS 2223051 (SIR; Anm. 12.5.1972; I-Prior. 9.5.1972).
I: TeoremacВ® (SIR)
Glutethimid 77-21-4
2-ethyl-2-phenylglutarimide
Hypnoticum
Glutethimid - Glybuzol - Glyconiazid G 447
^CHz
СЃРѕРѕСЃРЅР·
РЅ _СЃРіРЅ5 СЃ
NC Рџ
C2H5
C2H5
H3COOC
Acryisaure- 2-Phenyl-methylester butyromtril
USP 2673205 (Ciba; ert. 1954; CH-Prior. 1951).
DBP 950193 (Ciba; Anm. 1952; CH-Prior. 1951).
D: DoridenВ® (Ciba) J. DoridenВ® (Ciba-Geigy-Takeda)
F: DorideneВ® (Ciba) USA: DoridenВ® (USV)
GB: DoridenВ® (Ciba) Glutethimide (Lederle)
I: DoridenВ® (Ciba)
GlybliZOl 1492-02-0 Antidiabeticum (Desaglybuzole)
/V-(5~rerr-butyl-l,3,4-thiadiazol-2-yl)benzenesulfonamide
^~\-S02-0 + (H3Cl3C^S^-NH2 Pyr.d,n д (H3C)3C-^S^NH-S02-^ ^ \=/ N—N N-N
Benzolsulfonyl- 2-Ammo-5-(erf- ! Glybuzol
chlorid butyl-1,3,4-thiadiazol
GB-P 822947 (Smith + Nephew; Anm. 1957; Laufzeit ab 1958). FP-M 3389 (Rhone-Poulenc; Anm. 27.1.1964).
J: GludiaseВ® (Kyowa Hakko)
Glyconiazid 3691 -74-5 Tuberkulostaticum (Gluconiazid)
' Glucuronic acid, y-lactone, l-[(4-pyridinylcarbonyl)hydrazone]
0 OH I ___OH
\4 1 Hv В»
C-CH^-O^o N\_/ C-NH-N=CH-CH „0^
C-CH^.U^.0 ,N '>-C-NH-N=CH-CH_Owo
0-frNH-NH2 + н' уХ — ^ tr
0 но ОН НсГЛн
Isomcotinsaure-hydrazid D-Glucuronolacton Glyconiazid (Isomaztd, s. S. 503) — - ----
USP 2940899 (Univ. of California; ert. 14.6.1960; Prior. 28.9.1953).
P.P.T. Sah, J. Am. Chem. Soc. 75,2512 (1953).
D: GluronazidВ® (Hormonchemie) J: Hydronsan^ (Chugai)
I: GlucazideВ® (Stholl)
448 G Glycopyrroniumbromid - Glymidine
Glycopyrroniumbromid 596-51 -O Anticholinergicum
(Glycopyrrolate) Spasmolyticum
I, I-.dimethyl-3-hydroxypyrrolidinium bromide a-cyclopentylmandelate
MgBr
Q-t в– Рћ
—СООСНз
Phenylgl/oxyl- Cyclopentyt-
sauremethylester magnesium-
Рћ
РѕС‚- Cyclopentyl-
mandelsaure-
methylester
РЈ-\
N /[Naj
'РЎРћРћРЎРќР·
3-Hydroxy- .—/ \ _ /"-s
1-methyl- /\ СО —О—С 1
pyrrohdir
CH3
Methyl-
bromd
Q. ,0H
Чсо~°-Омгснз
I
CH3
Glycopyrroniumbromid
USP 2956062 (A. H. Robins; ert. 11.10.1960; Prior, 26.2,1959).
D: RobinulВ® (Brenner) J: RobinuiВ® (Kaken)
F: AsecrylВ® (Martinet) USA: RobinulВ® (Robins)
GB: RobinulВ® (Robins)
Glymidine 339-44-6 Antidiabeticum
(Glycodiazin; Sodium Glymidine) 3459-20-9 Na-Salz
[/V-[5-(2-methoxyethoxy)-2~pyrimidmyl]benzene-sulfonamide]
Н3Сч Н3СО”СН2-СН2-Оч
N-CHO + C0CIZ + РЎРќ-РЎРќ2-0-РЎРќ2-РЎРќ2-0РЎРќР·
H3C H3CO-CH2-CH2-O
Dimethyl- Phosgen 1,1,2-Tris-(2-methoxyethoxy)-ethan
formamid
H3C
_^ N-CHn
*■НзС7 XC-Q—CH2-CH2-OCH3 OHC
NH
_NH; ,
Berzolsulfonyi-guanidin j \—/ 1,1
Glymidine
^^-S03- NH-f ^РРѕ - РЎРќРі - РЎРќРі - РћРЎРќР·
DOT 1,72 (1965); 2,104 (1966).
USP 3275635 (Schering AG; ert. 27.9.1966; D-Prior. 18.10.1960,22.2.1961,23.2.1961). DAS 1445 142 (Schering AG; Anm. 22.2.1961).
DAS 1445 146 (Schering AG; Anm. 9.9.1961); Zusatz zu DAS 1445142).
K. Gutsche et al., Arzneim.-Forsch. 14, 373 (1964).
Glymidine - Griseofulvin - Guaiphenesin G 449
D: RedulВ® (Bayer-Schering) GB; RedulВ® plus (Bayer-Schering)- I: Komb. mit Buformin F: GlyconormalВ® (Bayer Pharma) J: GondafonВ® (SEPPS) GondafonВ® (Schering-Chemicals) GlycanolВ® (Bayer) GondafonВ® (Schering) LycanolВ® (Bayer)
